Federal contractor · BALTIMORE, MD

ACCELEVIR DIAGNOSTICS LLC

No contract obligations recorded for ACCELEVIR DIAGNOSTICS LLC in FY2026. Since FY2019: $2.3M. It also received $1.3M in federal grants and other assistance in FY2026.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
F6SKM7YHCUS7
Parent company
ACCELEVIR DIAGNOSTICS LLC
Small businessWoman-owned
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 13.5KFY2019
  2. 300KFY2020
  3. 0FY2021
  4. 0FY2022
  5. 2MFY2023

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for ACCELEVIR DIAGNOSTICS LLC in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

ACCELEVIR DIAGNOSTICS LLC received $1.3M in federal assistance in FY2026, on 4 actions (0 new awards), +73% vs FY2025. Its largest program was 93.855 · Allergy and Infectious Diseases Research ($1.3M).

Assistance · FY2026
$1.3M
New awards
0
Actions
4
Since FY2021
$7.1M

Assistance by fiscal year

  1. 1.3MFY2021
  2. 1.5MFY2022
  3. 1.5MFY2023
  4. 749.6KFY2024
  5. 755.3KFY2025
  6. 1.3MFY2026

By type

  1. Grants$1.3M100%

Top programs

  1. 93.855 · Allergy and Infectious Diseases Research$1.3M100%

Awarding agencies

  1. National Institutes of Health$1.3M100%
    Department of Health and Human Services

Largest awards

  1. CENTRALIZED RESOURCE TO ACCURATELY QUANTIFY LATENT AND EXPRESSED HIV RESERVOIRS$4.9M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Cooperative agreement· Mar 26, 2021 – May 11, 2026· U24AI143502
  2. CENTRALIZED RESOURCE TO ACCURATELY QUANTIFY LATENT AND EXPRESSED HIVRESERVOIRS - PROJECT SUMMARY/ABSTRACT HUMAN IMMUNODEFICIENCY VIRUS…$2.1M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Apr 9, 2025 – Sep 17, 2026· R24AI143502

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 3, 2026, loaded Oct 3, 2026 · FY2021–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 3, 2026, loaded Oct 3, 2026.